Abstracts Archive - Page 1716 of 2607 - ACR Meeting Abstracts

Abstract Number: 1752 • 2016 ACR/ARHP Annual Meeting
IL-23 Promotes the Generation of DNT Cells and Shifts the Balance Between IL-2 and IL-17 Production in Murine and Human SLE
Hong Dai^1,2, Fan He^1,2, George C. Tsokos^1,2 and Vasileios C. Kyttaris^1,2, ¹Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ²Harvard Medical School, Boston, MA
Background/Purpose: MRL/lpr mice develop a chronic inflammatory disease characterized by accumulation of CD4-CD8-B220+T cells mimicking human lupus; IL-23 driven IL-17 producing cell contribute to lupus…
Abstract Number: 1753 • 2016 ACR/ARHP Annual Meeting
Signal Transducer and Activator of Transcription (STAT) 3 Regulates Tcrαβ+CD4-CD8- T Cells in Systemic Lupus Erythematosus (SLE)
Fan He^1,2, Hao Li^1,2, George C. Tsokos^1,2 and Vasileios C. Kyttaris^1,2, ¹Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ²Harvard Medical School, Boston, MA
Background/Purpose: TCRαβ+CD4-CD8-T cells (double negative T cells, DNT) have been reported to produce inflammatory cytokines such as IL-17, and infiltrate the kidneys of patients with…
Abstract Number: 1754 • 2016 ACR/ARHP Annual Meeting
Double-Negative T (DNT) Cell over-Expressing PD-1 and Helios Is Responsible for Lupus Tissue Injury in Systemic Lupus Erythematosus (SLE): Direct Proof That Increased Interferon Alpha (IFNα) Expression Is Sufficient to Induce SLE in Ifnα-Transgenic Mice
Ken Tsumiyama¹, Chieri Akiyama², Yumi Miyazaki¹, Yasushi Miura², Akira Hashiramoto² and Shunichi Shiozawa¹, ¹Department of Medicine, Rheumatic Diseases Unit, Kyushu University Beppu Hospital, Beppu, Japan, ²Department of Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan
Background/Purpose: Previous studies strongly suggest that interferon α (IFNα) may be the principal driver of SLE, where increased IFNα and IFNα-regulated gene transcripts explain many of the immune…
Abstract Number: 1755 • 2016 ACR/ARHP Annual Meeting
Dendritic Cell-Specific Loss of Caspase 8 Incites Symptoms of Neuropsychiatric Systemic Lupus Erythematosus
Hadijat Makinde¹, Harris R. Perlman² and Carla Cuda¹, ¹Northwestern University, Chicago, IL, ²Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL
Background/Purpose: Previous studies implicate dendritic cells (DCs) in the initiation and persistence of systemic lupus erythematosus (SLE), and although DCs from SLE patients exhibit elevated…
Abstract Number: 1756 • 2016 ACR/ARHP Annual Meeting
Novel Role of Rho Kinase in Neutrophil Netosis during UVB Induced-Skin Inflammation
Ming-Lin Liu^1,2, Meena Sharma^2,3 and Victoria P. Werth^4,5, ¹Department of Dermatology,, Philadelphia V.A. Medical Center, Philadelphia, PA, ²Department of Dermatology, University of Pennsylvania, Philadelphia, PA, ³Department of Dermatology, Philadelphia V.A. Medical Center, Philadelphia, PA, ⁴Dermatology, University of Pennsylvania, Philadelphia, PA, ⁵Philadelphia V.A. Medical Center, Philidelphia, PA
Background/Purpose: Skin inflammation appears in cutaneous or systemic lupus erythematosus. Ultraviolet B (UVB) is an important environmental trigger of skin inflammation in lupus. Mechanisms linking…
Abstract Number: 1757 • 2016 ACR/ARHP Annual Meeting
Association of the Lupus Low Disease Activity State (LLDAS) with Health-Related Quality of Life
Vera Golder¹, Rangi Kandane-Rathnayake², Alberta Y. Hoi³, Molla Huq⁴, Worawit Louthrenoo⁵, Yuan An⁶, Zhanguo Li⁶, Shue Fen Luo⁷, Sargunan Sockalingam⁸, Chak Sing Lau⁹, Mo Yin Mok¹⁰, Aisha Lateef¹¹, Kate Franklyn³, Susan Morton¹², Sandra V. Navarra¹³, Leonid Zamora¹³, Yeong-Jian Wu⁷, Laniyati Hamijoyo¹⁴, Madelynn Chan¹⁵, Sean O'Neill¹⁶, Fiona Goldblatt¹⁷, Mandana Nikpour¹⁸, Eric F Morand³ and Asia Pacific Lupus Collaboration, ¹Southern Clinical School, Centre for Inflammatory Diseases, Monash University, Melbourne, Australia, ²Rheumatology, Monash University, Melbourne, Australia, ³Centre for Inflammatory Diseases, Monash University, Melbourne, Australia, ⁴Department of Medicine (Rheumatology), Melbourne University, Melbourne, Australia, ⁵Division of Rheumatology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand, ⁶Peking University People's Hospital, Beijing, China, ⁷Chang Gung University, Taoyuan County, Taiwan, ⁸University of Malaya, Kuala Lumpur, Malaysia, ⁹Univ Dept of Medicine, Queen Mary Hospital, Hong Kong, Hong Kong, ¹⁰Queen Mary Hospital, Hong Kong, Hong Kong, ¹¹Medicine/Rheumatology, National University Health System, Singapore, Singapore, ¹²Monash Health, Melbourne, Australia, ¹³Rheumatology, University of Santo Tomas Hospital, Manila, Philippines, ¹⁴University of Padjadjaran, Bandung, Indonesia, ¹⁵Tan Tock Seng Hospital, Singapore, Singapore, ¹⁶University of New South Wales, Sydney, Australia, ¹⁷Royal Adelaide Hospital, Adelaide, Australia, ¹⁸Melbourne University, Melbourne, Australia
Background/Purpose: Systemic lupus erythematosus (SLE) is associated with significant impairment of health-related quality of life (HR-QoL). Recently, meeting a definition of a Lupus Low Disease…
Abstract Number: 1758 • 2016 ACR/ARHP Annual Meeting
Physical Activity and Sedentary Behaviour in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
Alexandra Legge¹, John Hanly² and Chris Blanchard¹, ¹Department of Medicine, Dalhousie University, Halifax, NS, Canada, ²Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada
Background/Purpose: Patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are at increased risk for premature cardiovascular disease. As sedentary behaviour and lack of…
Abstract Number: 1759 • 2016 ACR/ARHP Annual Meeting
Sleep Disturbance Is Associated with Worsening Patient-Reported Outcomes over Two Years in Systemic Lupus Erythematosus (SLE)
Patricia P. Katz¹, Laura Trupin¹, Gabriela Schmajuk², Jinoos Yazdany¹, Edward H. Yelin¹ and Lindsey A. Criswell³, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, ³Division of Rheumatology, UCSF, San Francisco, CA
Background/Purpose: Although studies to date have suggested sleep disturbance among individuals with SLE, prior studies have been small and have examined a limited number of…
Abstract Number: 1760 • 2016 ACR/ARHP Annual Meeting
Systemic Lupus Erythematosus in Immigrants: Results from the 1000 Canadian Faces of Lupus Study
Amber Cogar¹, Janet E. Pope², Earl Silverman³, Paul R. Fortin⁴, Carol Hitchon⁵, Ann E. Clarke⁶, Christian Pineau⁷, Sasha Bernatsky^8,9, C Douglas Smith¹⁰, Marie Hudson¹¹, Adam Huber¹², Lori B. Tucker¹³, Michel Zummer¹⁴, Gaëlle Chédeville¹⁵, Hector Arbillaga¹⁶, Deborah M. Levy¹⁷, Christine A. Peschken¹⁸ and Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus, ¹Medicine, University of Manitoba, Winnipeg, MB, Canada, ²University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴Medicine, CHU de Québec - Université Laval, Québec, QC, Canada, ⁵University of Manitoba, Winnipeg, MB, Canada, ⁶Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ⁷Rheumatology, MUHC, Montreal, QC, Canada, ⁸Division of Rheumatolog, McGill University Health Center, Montreal, QC, Canada, ⁹Division of Rheumatology and Clinical Epidemiology, McGill University, Montreal, Quebec, QC, Canada, ¹⁰The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, ¹¹Medicine/Rheumatology, Jewish General Hospital, Lady Davis Research Institute, Montreal, QC, Canada, ¹²IWK Health Centre, Halifax, NS, Canada, ¹³Pediatric Rheum/Rm K4-120, BC Childrens Hospital, Vancouver, BC, Canada, ¹⁴Rheumatology, Ch Maisonneuve-Rosemont, Montreal, QC, Canada, ¹⁵Rheumatology, McGill University, Montreal, QC, Canada, ¹⁶Calgary Rheumatology, Calgary, AB, Canada, ¹⁷Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁸Arthritis Center, University of Manitoba, Winnipeg, MB, Canada
Background/Purpose: Ethnic differences in SLE are well known, but little is known about SLE in patients who have immigrated to North America from elsewhere in…
Abstract Number: 1761 • 2016 ACR/ARHP Annual Meeting
Fatigue in Patients with Systemic Lupus Erythematosus Is Independent of Their Disease Activity but Dependent on Their Damage Accrual and Body Mass Index
Adam Munday¹, Zerai G. Manna¹, Sarfaraz Hasni¹, Randall Keyser², Liana Wooten² and Ann Biehl³, ¹National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ²George Mason University Department of Rehabilitation Science, Fairfax, VA, ³Department of Pharmacy, National Institutes of Health Clinical Center, Bethesda, MD
Background/Purpose: Fatigue is omnipresent in patients with SLE. According to one study 80-90 % of the subjects report some degree of fatigue. This has huge…
Abstract Number: 1762 • 2016 ACR/ARHP Annual Meeting
Systemic Lupus Erythematosus and the Evaluation of Poor Sleep
Philip Chu¹, Alicia Hinze², Nancy Mathis³, Lacey Feigl⁴, Noor Al-Hammadi⁵, Seth Eisen⁶, Yo-El Ju⁷ and Alfred Kim⁸, ¹Internal Medicine, Washington University School of Medicine, St Louis, MO, ²Johns Hopkins University, Baltimore, MD, ³Rheumatology, Washington University School of Medicine, Saint Louis, MO, ⁴Washington University School of Medicine, St Louis, MO, ⁵Division of Biostatistics, Washington University School of Medicine, St Louis, MO, ⁶Division of Rheumatology, Washington University School of Medicine, St Louis, MO, ⁷Neurology, Washington University School of Medicine, Saint Louis, MO, ⁸IM/Div of Rheumatology, Washington University School of Medicine, St. Louis, MO
Background/Purpose: Poor sleep quality is an underappreciated complaint commonly observed in patients with SLE. We hypothesize that poor sleep quality contributes to worsening lupus disease…
Abstract Number: 1763 • 2016 ACR/ARHP Annual Meeting
Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus Following 7 Years of Treatment Exposure: Impact of Clinical Characteristics over Time
Vibeke Strand¹, Pam Berry², Xiwu Lin², Yumi Asukai³, James Fettiplace³ and Sulabha Ramachandran², ¹Stanford University School of Medicine, Palo Alto, CA, ²GSK, Philadelphia, PA, ³GSK, Uxbridge, Middlesex, United Kingdom
Background/Purpose: Despite improvements in medical care leading to improved survival, systemic lupus erythematosus (SLE) adversely affects patients’ health related quality of life (HRQoL). To explore…
Abstract Number: 1764 • 2016 ACR/ARHP Annual Meeting
Effect of Disease Remission on Organ Damage and Quality of Life in Chinese Patients with Systemic Lupus Erythematosus
Chi Chiu Mok¹, Ling Yin Ho², Sau Mei Tse¹ and Kar Li Chan¹, ¹Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, ²Dept of Medicine, Tuen Mun Hospital, Hong Kong SAR, Hong Kong
Background/Purpose: To study the effect of disease remission on quality of life and organ damage in patients with systemic lupus erythematosus. Methods: Consecutive patients who fulfilled the…
Abstract Number: 1765 • 2016 ACR/ARHP Annual Meeting
Minimal Clinically Important Differences for Generic Patient Reported Outcomes Tools in SLE
Hervé Devilliers¹, Narender Annapureddy² and Meenakshi Jolly³, ¹Department of Internal Medicine and Systemic Diseases, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, ²Rheumatology and Immunology, Vanderbilt University, Nashville, TN, ³Department of Medicine, Section of Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Patients with Systemic lupus erythematosus (SLE) have significant impairment in quality of life (QOL). Health related QOL (HRQOL) is one of the four established…
Abstract Number: 1766 • 2016 ACR/ARHP Annual Meeting
Impact of Depression on SLE Flares
Shikha Rathi¹, Alexis Zavitsanos², King Soon Goh¹, Roberto Caricchio¹ and Lauren Freid¹, ¹Temple University Hospital, Philadelphia, PA, ²Rheumatology, Temple University Hospital, Philadelphia, PA
Background/Purpose: Neuropsychiatric systemic lupus erythematosus (NPSLE) involves a wide range of peripheral and central neuropsychiatric manifestations. Depression is one of those and is very common…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].